Skip to main content
. 2022 Nov 29;10(1):e200065. doi: 10.1212/NXI.0000000000200065

Table 1.

Demographics, Investigations, Treatment at First Disease Event, Overall Disease Course, and Outcome in the Total Pediatric Cohort of Patients With MOGAD (A), in Children With Monophasic vs Relapsing Disease (B), and in Patients With EDSS 0 vs EDSS > 0 at Last Follow-up (C) (Univariate Analysis)

graphic file with name NXI-2022-200072t1.jpg